SCHEMBL15539532

SCHEMBL15539532

CC(C)(F)CN1CCCCC1CN(Cc1ccccc1)c1ccc(Br)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 3/20 0.40
ATM Q13315 1/20 0.36
CHRM3 P20309 3/20 0.35
CHRM2 P08172 2/20 0.35
NR1H2 P55055 3/20 0.34
NR1H3 Q13133 3/20 0.34
REN P00797 2/20 0.34
CYP1A2 P05177 2/20 0.34
MAPK1 P28482 1/20 0.34
LTA4H P09960 1/20 0.34
CYP2C19 P33261 3/20 0.34
KCNH2 Q12809 2/20 0.34
HRH3 Q9Y5N1 1/20 0.34
LMNA P02545 2/20 0.33
CYP3A4 P08684 2/20 0.33
MEN1 O00255 1/20 0.33
CYP2D6 P10635 1/20 0.33
TSHR P16473 1/20 0.33
KMT2A Q03164 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15539893 0.80 ACHE (0.41) CHRM3CHRM2NR1H2NR1H3CYP3A4
SCHEMBL15558242 0.74 ACHE (0.40) CHRM3CHRM2NR1H2NR1H3SLC6A2
SCHEMBL15537841 0.72 ACHE (0.39) CHRM3CHRM2RENCYP2C19TSHR
SCHEMBL15538825 0.71 CHRM2 (0.43) CHRM3CHRM2CYP3A4SLC6A2SLC6A4
SCHEMBL15538277 0.69 NPC1 (0.42) CHRM3CHRM2NR1H2NR1H3CHRM1
SCHEMBL2586563 0.66 CYP2C19 (0.64) NR1H2NR1H3CYP1A2MAPK1CYP2C19
SCHEMBL15538837 0.66 KDM4E (0.50) MEN1KMT2ASMN1; SMN2
SCHEMBL26619452 0.65 OPRD1 (0.58) OPRD1LTA4HHRH3ALDH1A1
SCHEMBL26619435 0.65 SIGMAR1 (0.50) OPRD1LTA4HHRH3SMN1; SMN2
Hydrochloric Acid SCHEMBL15540120 0.64 SLC6A2 (0.48) RENCYP1A2CYP2C19KCNH2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US disclosed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP disclosed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GPR84 OPRD1 318/4885ATM 4328/4885CHRM3 458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.